MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 31, 2008; DOI: 10.1124/mol.108.048900


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.108.048900v1
74/5/1372    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Paproski, R. J.
Right arrow Articles by Cass, C. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paproski, R. J.
Right arrow Articles by Cass, C. E.


Received for publication May 19, 2008.
Revised July 29, 2008.
Accepted for publication July 30, 2008.

The Role of Human Nucleoside Transporters in Uptake of 3'-Deoxy-3'-Fluorothymidine

Robert J. Paproski 1, Amy M. L. Ng 1, Sylvia Y. M. Yao 1, Kathryn Graham 1, James D. Young 1, Carol E. Cass 1*

1 University of Alberta

* Address correspondence to: E-mail: carol.cass{at}cancerboard.ab.ca

Abstract

3'-Deoxy-3'-fluorothymidine (FLT) is a positron emission tomography (PET) tracer used to identify proliferating tumor cells. The purpose of this study was to characterize FLT transport by each human nucleoside transporter (hNT) and to determine the role of hNTs for FLT uptake in various human cancer cell lines. FLT binding to hNTs was monitored by the inhibitory effects of FLT on 3H-uridine uptake in yeast cells producing recombinant hNT proteins. hCNT1 displayed the lowest FLT Ki value for inhibition of 3H-uridine uptake, followed by hCNT3, hENT2, hENT1, and hCNT2. 3H-FLT was efficiently transported in Xenopus laevis oocytes individually producing hENT1, hENT2, hCNT1 or hCNT3. 3H-FLT uptake in MCF-7, A549, U251, A498, MIA PaCa-2, and Capan-2 cells was inhibited at least 50% by the hENT1 inhibitor nitrobenzylmercaptopurine ribonucleoside (NBMPR). Using real-time PCR, hENT1 and hENT2 had the most abundant hNT transcripts in all cell lines. Cell lines also underwent (i) 3H-NBMPR equilibrium binding assays with or without 5-S-{2-(1-[(fluorescein-5-yl)thioureido]hexanamido)ethyl}-6-N-(4-nitrobenzyl)-5-thioadenosine (FTH-SAENTA), a membrane impermeable NBMPR analog, to determine plama membrane hENT1 levels, and (ii) dose-response NBMPR inhibition of 3H-FLT uptake. MCF-7, A549, and Capan-2 cells displayed NBMPR IC50 values that were smaller or equal to NBMPR Kd values, suggesting that 50% inhibition of hENT1 reduced 3H-FLT uptake by at least 50%. A strong correlation between extracellular NBMPR binding sites/cell and 3H-FLT uptake was observed for all cell lines except MIA PaCa-2. These data suggest that plasma membrane hNTs (especially hENT1) are important determinants of cellular FLT uptake.


Key words: Nucleoside/Nucleotide, Nucleoside/Nucleotide derivatives





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics